Skip to content

Harrow HROW Noncash Lease Expense

Noncash Lease Expense at other companies

MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$229K+8.0%
Kohl's logo
Kohl'sKSS
$22M+4.8%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$980K+14.4%
Remitly Global, Inc. logo
Remitly Global, Inc.RELY
$765K-20.2%
PROG Holdings logo
PROG HoldingsPRG
-$732K+28.6%
Rush Street Interactive logo
Rush Street InteractiveRSI
$265K+18.3%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept HROW:NoncashLeaseExpense.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's noncash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's noncash lease expense?
Harrow (HROW) reported noncash lease expense of $192K in Q1 2026.
How has Harrow's noncash lease expense changed year-over-year?
Harrow's noncash lease expense decreased by 11.5% year-over-year, from $217K to $192K.
What does noncash lease expense mean?
Represents the portion of lease expenses recognized in the income statement that does not involve an immediate cash outflow. This adjustment is added back to net income to reconcile cash flow from operations, reflecting the non-cash nature of right-of-use asset amortization.